Highlights HARMONY Alliance attendance at the 61st ASH Annual ...
Press Release: HARMONY Big Data Platform can improve prognostic ...
HARMONY wins ISPOR’s New Investigator Award 2019
Highlights from HARMONY's 4th General Assembly, hosted by HARMONY ...
Meet us at these upcoming international conferences in November ...
Progress Update: HARMONY gains momentum
September 2019: Supporting Blood cancer awareness month!
4th General Assembly organized in Florence, Italy
Unique video: Aggregated data from 5 AML studies showing
Meet HARMONY at EHA24, 13-16 June, Amsterdam
Moving Forward: First Data Transferred Into The HARMONY Big
HARMONY Anonymization Concept Reconciles Data Quality, Safety, ...
The “Summary report of the Heads of Medicines Agencies” ...
EHA and HARMONY organize the 2nd meeting for the HM Key Opinion ...
Public-private partnership for Big Data in Hematology
HARMONY and HARMONY PLUS are funded through the Innovative Medicines Initiative (IMI), Europe's largest public-private initiative aiming to speed up the development of better and safer medicines for patients. Funding is received from the IMI 2 Joint Undertaking and is listed under grant agreement for HARMONY No. 116026 and grant agreement for HARMONY PLUS No. 945406. This Joint Undertaking receives support from the European Union’s Horizon 2020 Research and Innovation Programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA).
HARMONY Coordination Office
Institute of Biomedical Research of
Salamanca (IBSAL)
Salamanca, Spain
HARMONY Communications
European Hematology Association (EHA)
The Hague, The Netherlands